Vendor-neutral value Cerno Bioscience offers a software platform that works across all mass spectrometry instruments, presenting a compelling upsell for labs standardizing workflows or expanding instrument access without vendor lock-in.

Performance enhancement The technology promises improved MS signal correction and accuracy for small and large molecules, enabling more confident analyses and potential justification for higher-value software licenses or expanded feature sets.

ASMS engagement Active participation in major conferences (ASMS 2025 and 2026) indicates a strategy geared toward direct customer outreach; target conversations could focus on instrument-agnostic efficiency gains and workflow integration.

Growing footprint With a small team and revenue in the lower-to-mid range, there is an opportunity to package scalable offerings, partner programs, or channel strategies to accelerate sales while maintaining agile product delivery.

Product legacy A history of iterative releases (MassWorks, GC/ID, automated systems) positions the company to upsell legacy customers with next-generation modules and maintenance plans, and to expand into related MS workflow solutions.